Mitomycin resistance in mammalian cells expressing the bacterial mitomycin C resistance protein MCRA

AUTOR(ES)

Belcourt, Michael F.

FONTE

The National Academy of Sciences

RESUMO

The mitomycin C-resistance gene, mcrA, of Streptomyces lavendulae produces MCRA, a protein that protects this microorganism from its own antibiotic, the antitumor drug mitomycin C. Expression of the bacterial mcrA gene in mammalian Chinese hamster ovary cells causes profound resistance to mitomycin C and to its structurally related analog porfiromycin under aerobic conditions but produces little change in drug sensitivity under hypoxia. The mitomycins are prodrugs that are enzymatically reduced and activated intracellularly, producing cytotoxic semiquinone anion radical and hydroquinone reduction intermediates. In vitro, MCRA protects DNA from cross-linking by the hydroquinone reduction intermediate of these mitomycins by oxidizing the hydroquinone back to the parent molecule; thus, MCRA acts as a hydroquinone oxidase. These findings suggest potential therapeutic applications for MCRA in the treatment of cancer with the mitomycins and imply that intrinsic or selected mitomycin C resistance in mammalian cells may not be due solely to decreased bioactivation, as has been hypothesized previously, but instead could involve an MCRA-like mechanism.

Documentos Relacionados

• Inducible overproduction of the mouse c-myc protein in mammalian cells.
• Expressing functional siRNAs in mammalian cells using convergent transcription
• Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells.
• Expression of processed core protein of hepatitis C virus in mammalian cells.
• Enhanced Arsenic Accumulation in Engineered Bacterial Cells Expressing ArsR